Nurix Therapeutics, Inc. Public Market Comparables
Find the most relevant public market comparables for Nurix Therapeutics, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines to improve treatment options for patients with cancer and inflammatory diseases. Their approach involves modulating cellular protein levels using oral, small molecule therapies.
Business Model
Discovery, development, and commercialization of targeted protein degradation medicines.
Target Customers
Patients with cancer and inflammatory diseases
Specific Focus
Targeted protein degradation medicines
Location
San Francisco, California
CEO
Arthur T. Sands
Industry
Life sciences
Sub Sector
Biopharmaceutical
3yr Revenue Growth
332%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Nurix Therapeutics, Inc. in the Biotechnology & Drugs sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Nurix Therapeutics, Inc.? Our platform provides detailed analysis of Nurix Therapeutics, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Nurix Therapeutics, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Nurix Therapeutics, Inc. Compset
As a leading player in the Life sciences industry within the Biotechnology & Drugs sector, Nurix Therapeutics, Inc. operates in the specialized Biopharmaceutical sub-sector. Understanding how Nurix Therapeutics, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biopharmaceutical space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Sutro Biopharma Inc.
Biotechnology • Life sciences
Sutro Biopharma, Inc. is a clinical-stage oncology company focused on discovering and developing precisely designed cancer therapeutics using its proprietary cell-free protein synthesis platform, XpressCF+. The company develops next-generation protein therapeutics for cancer and autoimmune disorders, focusing on antibody-drug conjugates (ADCs), cytokine-based immuno-oncology therapies, and bispecific antibodies.
Arvinas Inc.
Pharmaceuticals & Biotech • Life sciences
Arvinas is a clinical-stage biopharmaceutical company focused on developing new therapeutics for cancers and other difficult-to-treat diseases. Their proprietary PROTAC® protein degraders harness the body's natural protein disposal system to degrade disease-causing proteins.
Aclaris Therapeutics Inc.
Biotechnology • Life sciences
Aclaris Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics (identifying and developing therapies for immuno-inflammatory diseases) and contract research (providing laboratory services). A majority of its revenue comes from the therapeutics segment.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Nurix Therapeutics, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free